Schalper, Kurt A.
Rodriguez-Ruiz, Maria E.
Diez-Valle, Ricardo
López-Janeiro, Alvaro
Porciuncula, Angelo
Idoate, Miguel A.
Inogés, Susana
de Andrea, Carlos
López-Diaz de Cerio, Ascensión
Tejada, Sonia
Berraondo, Pedro http://orcid.org/0000-0001-7410-1865
Villarroel-Espindola, Franz
Choi, Jungmin
Gúrpide, Alfonso
Giraldez, Miriam
Goicoechea, Iosune
Gallego Perez-Larraya, Jaime http://orcid.org/0000-0003-2969-0116
Sanmamed, Miguel F.
Perez-Gracia, Jose L. http://orcid.org/0000-0003-4941-9075
Melero, Ignacio http://orcid.org/0000-0002-1360-348X
Article History
Received: 21 August 2018
Accepted: 17 December 2018
First Online: 11 February 2019
Competing interests
: K.A.S. is a consultant for Celgene, Moderna Therapeutics and Shattuck Labs and has received research funding from Vasculox, Moderna, Takeda, Surface Oncology, Tesaro, Pierre-Fabre, Merck and Bristol-Myers Squibb. I.M. is a consultant for BMS, Merck-Serono, Roche-Genetech, Tusk, Alligator, Genmab, Molecular Partners, F-Star, Bayer, Seattle Genetics and Alligator and has received research funding from BMS, Roche, Bioncotech and Alligator. J.L.P.-G. is a consultant for and has received research support, travel grants and lecture fees from BMS and Roche as well as research support and travel grants from MSD.